[1]
|
何宇, 石晶明. 葡萄膜炎的治疗进展[J]. 中国实用眼科杂志, 2012, 30(7): 765-768.
|
[2]
|
London, N.J., Rathinam, S.R. and Cunningham, E.J. (2010) The Epidemiology of Uveitis in Developing Countries. International Ophthalmology Clinics, 50, 1-17. https://doi.org/10.1097/IIO.0b013e3181d2cc6b
|
[3]
|
郑曰忠. 重视葡萄膜炎药物治疗研究, 提高葡萄膜炎药物治疗效果[J]. 中华眼底病杂志, 2010(5): 404-408.
|
[4]
|
郑曰忠. 葡萄膜炎的临床治疗研究进展[J]. 中华眼科杂志, 2008(10): 952-955.
|
[5]
|
张传宏, 薛黎萍. 非感染性葡萄膜炎药物治疗进展[J]. 国际眼科纵览, 2021, 45(2): 89-98.
|
[6]
|
Burkholder, B.M. and Jabs, D.A. (2021) Uveitis for the Non-Ophthalmologist. BMJ, 372, m4979.
https://doi.org/10.1136/bmj.m4979
|
[7]
|
中华医学会眼科学分会眼免疫学组. 我国急性前葡萄膜炎临床诊疗专家共识(2016年) [J]. 中华眼科杂志, 2016, 52(3): 164-166.
|
[8]
|
Gaudio, P. (2004) A Review of Evidence Guiding the Use of Corticosteroids in the Treatment of Intraocular Inflammation. Ocular Immunology and Inflammation, 12, 169-192. https://doi.org/10.1080/092739490500192
|
[9]
|
Modorati, G. and Miserocchi, E. (2012) Intravitreal In-jection Therapy in the Treatment of Noninfectious Uveitis. Developments in Ophthalmology, 51, 110-121. https://doi.org/10.1159/000336471
|
[10]
|
宋佳忆, 陈婷, 艾明. 玻璃体腔注药治疗非感染性葡萄膜炎黄斑水肿的研究现状与进展[J]. 中华眼底病杂志, 2022, 38(5): 410-414.
|
[11]
|
Sallam, A., Taylor, S.R., Habot-Wilner, Z., et al. (2012) Repeat Intravitreal Triamcinolone Acetonide Injections in Uveitic Macular Oedema. Acta Ophthalmologica, 90, e323-e325. https://doi.org/10.1111/j.1755-3768.2011.02247.x
|
[12]
|
Jaffe, G.J., Foster, C.S., Pavesio, C.E., et al. (2019) Effect of an Injectable Fluocinolone Acetonide Insert on Recurrence Rates in Chronic Noninfectious Uveitis Affecting the Posterior Segment: Twelve-Month Results. Ophthalmology, 126, 601-610. https://doi.org/10.1016/j.ophtha.2018.10.033
|
[13]
|
Bahadorani, S., Krambeer, C., Wannamaker, K., et al. (2018) The Effects of Repeated Ozurdex Injections on Ocular Hypertension. Clinical Ophthalmology, 12, 639-642. https://doi.org/10.2147/OPTH.S148990
|
[14]
|
Mathis, T., Cerquaglia, A., Weber, M., et al. (2021) Uveitis Treated with Dexamethasone Implant. Retina, 41, 620-629.
https://doi.org/10.1097/IAE.0000000000002901
|
[15]
|
Wakefield, D., McCluskey, P., Wildner, G., et al. (2017) Inflammatory Eye Disease: Pre-Treatment Assessment of Patients Prior to Commencing Immunosuppressive and Bio-logic Therapy: Recommendations from an Expert Committee. Autoimmunity Reviews, 16, 213-222. https://doi.org/10.1016/j.autrev.2017.01.003
|
[16]
|
Gangaputra, S., Newcomb, C.W., Liesegang, T.L., et al. (2009) Methotrexate for Ocular Inflammatory Diseases. Ophthalmology, 116, 2188-2198. https://doi.org/10.1016/j.ophtha.2009.04.020
|
[17]
|
Hatemi, G., Christensen, R., Bang, D., et al. (2018) 2018 Update of the EULAR Recommendations for the Management of Behcet’s Syndrome. Annals of Rheumatic Diseases, 77, 808-818.
https://doi.org/10.1136/annrheumdis-2018-213225
|
[18]
|
Pasadhika, S., Kempen, J.H., Newcomb, C.W., et al. (2009) Azathioprine for Ocular Inflammatory Diseases. The American Journal of Ophthalmology, 148, 500-509. https://doi.org/10.1016/j.ajo.2009.05.008
|
[19]
|
Kim, E.C. and Foster, C.S. (2006) Immunomodulatory Therapy for the Treatment of Ocular Inflammatory Disease: Evidence-Based Medicine Recommendations for Use. International Ophthalmology Clinics, 46, 141-164.
https://doi.org/10.1097/00004397-200604620-00013
|
[20]
|
Kacmaz, R.O., Kempen, J.H., Newcomb, C., et al. (2010) Cyclosporine for Ocular Inflammatory Diseases. Ophthalmology, 117, 576-584. https://doi.org/10.1016/j.ophtha.2009.08.010
|
[21]
|
Zaghetto, J.M., Yamamoto, M.M., Souza, M.B., et al. (2010) Chlorambucil and Cyclosporine A in Brazilian Patients with Behcet’s Disease Uveitis: A Retrospective Study. Arquivos Brasileiros de Oftalmologia, 73, 40-46.
https://doi.org/10.1590/S0004-27492010000100007
|
[22]
|
白琳, 杨培增. 白塞病葡萄膜炎的治疗与展望[J]. 中华实验眼科杂志, 2016, 34(8): 761-764.
|
[23]
|
樊帆, 周旻, 罗怡. 抗肿瘤坏死因子-α制剂治疗葡萄膜炎研究进展[J]. 中华眼科杂志, 2013, 49(3): 285-288.
|
[24]
|
张传宏, 胡淑娴, 潘燕婷, 等. 阿达木单抗治疗非感染性葡萄膜炎研究进展[J]. 国际眼科杂志, 2021, 21(9): 1561-1565.
|
[25]
|
彭宇, 邱新文, 叶波, 等. 阿达木单抗治疗非感染性葡萄膜炎[J]. 国际眼科纵览, 2022, 46(4): 336-340.
|
[26]
|
Diaz-Llopis, M., Garcia-Delpech, S., Salom, D., et al. (2008) Adalimumab Therapy for Refractory Uveitis: A Pilot Study. Journal of Ocular Pharmacology and Therapeutics, 24, 351-361. https://doi.org/10.1089/jop.2007.0104
|
[27]
|
Suhler, E.B., Adán, A., Brézin, A.P., et al. (2018) Safety and Efficacy of Adalimumab in Patients with Noninfectious Uveitis in an Ongoing Open-Label Study: VISUAL III. Ophthalmology, 125, 1075-1087.
https://doi.org/10.1016/j.ophtha.2017.12.039
|
[28]
|
Burmester, G.R., Gordon, K.B., Rosenbaum, J.T., et al. (2020) Long-Term Safety of Adalimumab in 29,967 Adult Patients from Global Clinical Trials across Multiple Indications: An Updated Analysis. Advances in Therapy, 37, 364-380.
https://doi.org/10.1007/s12325-019-01145-8
|
[29]
|
Srivastava, A., Rajappa, M. and Kaur, J. (2010) Uveitis: Mechanisms and Recent Advances in Therapy. Clinica Chimica Acta, 411, 1165-1171. https://doi.org/10.1016/j.cca.2010.04.017
|
[30]
|
De Kozak, Y., Thillaye-Goldenberg, B., Naud, M.C., et al. (2002) Inhibition of Experimental Autoimmune Uveoretinitis by Systemic and Subconjunctival Adenovirus-Mediated Transfer of the Viral IL-10 Gene. Clinical & Experimental Immunology, 130, 212-223. https://doi.org/10.1046/j.1365-2249.2002.01969.x
|
[31]
|
Trittibach, P., Barker, S.E., Broderick, C.A., et al. (2008) Lentiviral-Vector-Mediated Expression of Murine IL-1 Receptor Antagonist or IL-10 Reduces the Severity of Endo-toxin-Induced Uveitis. Gene Therapy, 15, 1478-1488.
https://doi.org/10.1038/gt.2008.109
|
[32]
|
Agarwal, R.K., Kang, Y., Zambidis, E., et al. (2000) Retroviral Gene Therapy with an Immunoglobulin-Antigen Fusion Construct Protects from Experimental Autoimmune Uveitis. Journal of Clinical Investigation, 106, 245-252.
https://doi.org/10.1172/JCI9168
|
[33]
|
Shen, W.Y., Yu, M.J., Barry, C.J., et al. (1998) Expression of Cell Adhesion Molecules and Vascular Endothelial Growth Factor in Experimental Choroidal Neovascularisation in the Rat. British Journal of Ophthalmology, 82, 1063-1071. https://doi.org/10.1136/bjo.82.9.1063
|
[34]
|
van de Stolpe, A. and van der Saag, P.T. (1996) Intercellular Adhesion Molecule-1. Journal of Molecular Medicine (Berlin), 74, 13-33. https://doi.org/10.1007/BF00202069
|
[35]
|
Hirano, Y., Sakurai, E., Matsubara, A., et al. (2010) Suppression of ICAM-1 in Retinal and Choroidal Endothelial Cells by Plasmid Small-Interfering RNAs in Vivo. Investigative Oph-thalmology & Visual Science, 51, 508-515.
https://doi.org/10.1167/iovs.09-3457
|
[36]
|
Hou, Y., Xing, L., Fu, S., et al. (2009) Down-Regulation of Inducible Co-Stimulator (ICOS) by Intravitreal Injection of Small Interfering RNA (siRNA) Plasmid Suppresses Ongoing Ex-perimental Autoimmune Uveoretinitis in Rats. Graefe’s Archive for Clinical and Experimental Ophthalmology, 247, 755-765.
https://doi.org/10.1007/s00417-008-1023-0
|